Skip to Content
Merck
CN

691771

Gadolinium

ingot, 99.99% trace rare earth metals basis

Sign In to View Organizational & Contract Pricing.

Select a Size

About This Item

Linear Formula:
Gd
CAS Number:
7440-54-2
Molecular Weight:
157.25
NACRES:
NA.23
PubChem Substance ID:
329761437
UNSPSC Code:
12352300
EC Number:
231-162-2
MDL number:
MFCD00011022

Key Documents

View All Documentation
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

Product Name

Gadolinium, ingot, 99.99% trace rare earth metals basis

InChI key

UIWYJDYFSGRHKR-UHFFFAOYSA-N

InChI

1S/Gd

SMILES string

[Gd]

assay

99.99% trace rare earth metals basis

form

ingot

reaction suitability

reagent type: catalyst
core: gadolinium

resistivity

126 μΩ-cm, 20°C

bp

3273 °C (lit.)

mp

1313 °C (lit.)

density

7.886 g/mL at 25 °C (lit.)

Looking for similar products? Visit Product Comparison Guide

General description

Curie Temperature: 293 K

pictograms

Flame
GHS02

signalword

Warning

hcodes

H261

Hazard Classifications

Water-react 3

Storage Class

4.3 - Hazardous materials which set free flammable gases upon contact with water

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type P3 (EN 143) respirator cartridges

Regulatory Information

新产品
This item has

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
MKCB5043
MKBZ0993V
MKBW6612V
MKBS9890V
MKBL0470V

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Stéphane Kremer et al.
Neurology, 81(3), 206-210 (2013-06-14)
The first goal of this study is to compare gadofosveset trisodium--a gadolinium agent that reversibly binds to albumin--to an extracellular contrast agent (Gd-DOTA) for the detection of multiple sclerosis lesions. The second goal is to determine the best postinjection time
Vanessa Wiggermann et al.
Neurology, 81(3), 211-218 (2013-06-14)
We investigated the evolution of new multiple sclerosis (MS) lesions over time using frequency shifts of the magnetic resonance (MR) signal. Twenty patients with relapsing-remitting MS were serially scanned for 6 months at 1-month intervals. Maps of MR frequency shifts
Yusuke Nishimura et al.
Journal of neurosurgery. Spine, 19(6), 716-720 (2013-10-08)
A spinal intradural extramedullary venous angioma is extremely rare and has not been previously reported. In this paper, the authors report on this entity with morphological and immunohistochemical evidence, and discuss the surgical strategy for its treatment. A 54-year-old woman
Tomas G Neilan et al.
Journal of the American College of Cardiology, 62(23), 2205-2214 (2013-09-03)
This study sought to identify the frequency, pattern, and prognostic significance of left ventricular (LV) late gadolinium enhancement (LGE) in patients with atrial fibrillation (AF). There are limited data on the presence, pattern, and prognostic significance of LV myocardial fibrosis
P Stephen Patrick et al.
Proceedings of the National Academy of Sciences of the United States of America, 111(1), 415-420 (2013-12-19)
The ability to track cells and their patterns of gene expression in living organisms can increase our understanding of tissue development and disease. Gene reporters for bioluminescence, fluorescence, radionuclide, and magnetic resonance imaging (MRI) have been described but these suffer
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service